At a glance
| Question | Semax | Selank |
|---|---|---|
| Research emphasis | Molecular responses in experimental ischemia | GABA-related molecular responses |
| Important context | Brain region, injury model and observation time | Cell system, selected genes and exposure conditions |
| Unresolved question | Which responses are causal and reproducible? | How do molecular readouts relate to functional outcomes? |
Compare evidence before conclusions
The shared keyword is a starting point, not evidence of equivalence. First identify the exact molecule or process. Then record the model, comparator, measured endpoint and observation period. Results from unrelated studies can illustrate different questions but cannot establish a winner.
The papers below are a selected reading list. They support the specific identities or experimental topics described; they are not all direct comparative studies. For production-route terminology, analytical validation provides an evaluation framework rather than proof of either route’s quality.
Read the full Semax reference and Selank reference for study-specific limitations. No dosing or personal-use guidance is provided.
Questions, answered.
Does this comparison establish which is better?
No. Different models, chemical identities and measured outcomes cannot be combined into a reliable superiority ranking. A direct comparison needs matched experimental conditions and an explicit endpoint.
What should a researcher verify first?
Verify the exact material identity, the experimental model and endpoint, and the original source. Match any commercial sample to its own lot-specific documentation.
Sources & reading notes
- The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis · Medvedeva EV et al. (2014)Source access: abstract.
- Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion · Sudarkina OY et al. (2021)Source access: abstract.
- Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission · Volkova A et al. (2016)Source access: abstract.
- GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells · Filatova E et al. (2017)Source access: abstract.